Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 18:00:00
Surgical Sci Se Rg (Stockholm)
Závěr k 13.2.2026 Změna (%) Změna (SEK) Objem obchodů (SEK)
25,92 4,85 1,20 7 365 841
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiSurgical Science Sweden AB
TickerSUS
Kmenové akcie:Ordinary Shares
RICSUSW.ST
ISINSE0014428512
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 30.09.2025 328
Akcie v oběhu k 30.09.2025 51 026 236
MěnaSEK
Kontaktní informace
UliceDrakegatan 7
MěstoGOETEBORG
PSČ412 50
ZeměSweden
Kontatní osoba 
Funkce kontaktní osoby 
Telefon46 317 416 560

Business Summary: Surgical Science Sweden AB is a Sweden-based company, which provides with virtual reality simulators for evidence based laparoscopic and endoscopic training. The systems comprise LapSim, EndoSim and TeamSim trainings. Each training combine graphics and cognitive instruction, imply navigation on touch screens and feature tactile feedback technology. The LapSim trainings consist of laparoscopic exercises that range from basic navigation to advanced suturing, the EndoSim endoscopic exercises range from functions of the scope handle and tube, to loop reduction. The TeamSim comprises procedure modules to train in a real world operation room environment and helps to build team communication skills in crisis and routine situations. The training systems are used by medical training centers and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Surgical Science Sweden AB revenues increased 14% to SEK723.5M. Net income decreased 65% to SEK33.6M. Revenues reflect Educational Products segment increase of 17% to SEK372M, Industry OEM segment increase of 12% to SEK351.5M, Europe segment increase of 53% to SEK141.8M, North and South America segment increase of 8% to SEK456.4M.
Odvětvová klasifikace
TRBC2012Medical Software & Technology Services
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
SICCommercial Physical Research



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardGisli Hennermark5315.05.202501.01.2015
Chief Executive OfficerTom Englund4801.10.202401.10.2024
Chief Financial OfficerAnna Ahlberg5401.01.2018
President - Research and DevelopmentRan Bronstein5901.01.2021
Chief Operating OfficerBoaz Tal5501.01.2021
Executive Vice President of International SalesDoron Zilberman6101.01.2021
Executive Vice President Products and MarketingInbal Mazor5401.01.2021
Executive Vice President - Industry/OEMNiclas Olsson5701.01.2022
Chief Technology OfficerAnders Larsson5001.01.1999